Public Health
Contact-tracing apps could help end coronavirus lockdown
A new University of Oxford study found that contact-tracing apps could help bring the coronavirus pandemic to an end without violating citizens' rights.
Your new sex ed teacher is a chatbot
This chatbot is filling in gaps in sex education by talking with teens to answer awkward questions about topics like health, sexuality, and identity.
Bill Gates is spending billions to produce 7 coronavirus vaccines
The Gates Foundation is building factories to manufacture seven promising coronavirus vaccines to prepare for mass production if any prove effective.
Group coronavirus testing helps make most of limited kits
Researchers across the globe are testing the efficacy of group coronavirus testing — using one kit for multiple patients — with promising results.
New tool seeks to protect those reusing coronavirus masks
A group of researchers launched a website that teaches healthcare workers everything they need to know about reusing coronavirus masks as safely as possible.
Genetic evidence debunks coronavirus conspiracy theories, scientists say
A team of researchers analyzed the COVID-19 coronavirus. Their findings debunk the conspiracy theory that the virus was lab-made.
Big tobacco announces "breakthrough" in plant-based coronavirus vaccine
A plant-based coronavirus vaccine developed by a subsidiary of British American Tobacco is now undergoing pre-clinical testing.
A promising vaccine candidate, new mutual-aid networks, and more COVID-19 updates
In our weekly news roundup, we take you inside the fight against COVID-19 to explore the solutions on the frontlines of an unprecedented global response.
New coronavirus vaccine candidate creates antibodies in mice
A new coronavirus vaccine candidate that delivers inoculation via a microneedle patch has shown promise in a peer-reviewed mouse study.
Silicon Valley fixes broken ventilators for coronavirus patients
Silicon Valley-based Bloom Energy has refurbished hundreds of ventilators for coronavirus patients in just a few weeks — and it shows no signs of slowing down.